{"Title": ["ABIO Jumps On Joining COVID-19 Drug Fray, GMAB Hits Trial Goal, IMRA On Watch", "Why Boeing Stock Is Up", "BUZZ-U.S. STOCKS ON THE MOVE-L Brands, Akorn, Aurora Cannabis", "Why Flexion Therapeutics Is Tumbling 10% Today", "BUZZ-U.S. STOCKS ON THE MOVE-Akorn, L Brands, Aurora Cannabis", "Flexion Therapeutics Inc (FLXN) Q1 2020 Earnings Call Transcript", "Flexion Therapeutics Inc (FLXN) Q4 2019 Earnings Call Transcript", "3 High-Risk, High-Reward Stocks That Have Massive Upside Potential", "ABIO Jumps On Joining COVID-19 Drug Fray, GMAB Hits Trial Goal, IMRA On Watch", "5 'Strong Buy' Biotech Stocks to Buy for 2020", "Health Care Sector Update for 12/27/2019: DCPH,MBOT,FLXN,MLNT", "Health Care Sector Update for 12/27/2019: MBOT,FLXN,MLNT", "Why Flexion Therapeutics Stock Is Flying Higher Today", "Health Care Sector Update for 12/27/2019: FLXN, FPRX, SPPI, JNJ, PFE, ABT, MRK, AMGN", "Flexion Awaits FDA Word On Revised Zilretta Label", "Should Investors Up the Ante on These 3 \u201cStrong Buy\u201d Stocks?", "3 Canadian Biotechs to Consider Buying Today", "5 Strong Buy Biotech Stocks With Rapidly Approaching Catalysts", "RETA Surges On Trial Data, RVNC On Track, All Eyes On RLMD Today", "Health Care Sector Update for 10/14/2019: CTST,APYX,FLXN,AGN,ABBV", "Health Care Sector Update for 10/14/2019: APYX,FLXN,AGN,ABBV", "Health Care Sector Update for 10/14/2019: IMRN, CERC, AYTU, FLXN, JNJ, PFE, ABT, MRK, AMGN", "3 Top Biotech Stocks With Major Catalysts in October", "Notable Wednesday Option Activity: FLXN, MYOK, GTS", "Flexion Therapeutics Inc (FLXN) Q3 2019 Earnings Call Transcript", "5 Strong Buy Biotech Stocks With Rapidly Approaching Catalysts", "RETA Surges On Trial Data, RVNC On Track, All Eyes On RLMD Today", "Health Care Sector Update for 10/14/2019: CTST,APYX,FLXN,AGN,ABBV", "Health Care Sector Update for 10/14/2019: APYX,FLXN,AGN,ABBV", "Health Care Sector Update for 10/14/2019: IMRN, CERC, AYTU, FLXN, JNJ, PFE, ABT, MRK, AMGN", "3 Top Biotech Stocks With Major Catalysts in October", "Flexion Therapeutics Inc (FLXN) Q4 2018 Earnings Conference Call Transcript", "Biotech Stocks Facing FDA Decision In October 2019", "Here's Why Flexion Therapeutics Rose 29.8% in January", "Flexion Starts Phase III Enrollment on Zilretta for Hip OA", "Here's Why Flexion Therapeutics Jumped 20.5% in November", "Flexion Therapeutics (FLXN) Reports Q3 Loss, Tops Revenue Estimates", "Commit To Buy Flexion Therapeutics At $12.50, Earn 8.1% Annualized Using Options", "Flexion Therapeutics Shares Cross Below 200 DMA", "5 Biotech Stocks That Could Be the Next Amgen", "Flexion Therapeutics (FLXN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release", "Why Flexion Therapeutics Jumped 12.6% Today", "After-Hours Earnings Report for March 8, 2018 : COO, MRVL, ZTO, FNSR, UNFI, PAY, MYOK, TERP, MMI, BOLD, FLXN, KMG", "3 Biotechs Launching Their First Commercial Drugs in 2018", "Flexion Therapeutics Getting Closer To Key Technical Measure", "Notable Monday Option Activity: KHC, RGLD, FLXN", "2018 Is a Critical Year for These 3 Small Commercial-Stage Biotech Stocks", "Top Insiders Are Buying These 3 'Strong Buy' Healthcare Stocks", "Why Flexion Therapeutics (FLXN) Could Be Positioned for a Slump", "Stocks To Watch: Flexion Therapeutics Sees RS Rating Jump To 83", "This Small-Cap Biotech Stock Is Onto Something Big", "Notable Monday Option Activity: FLXN, VER, AVGO", "Stocks To Watch: Flexion Therapeutics Sees Relative Strength Rating Jump To 88", "Health Care Sector Update for 11/24/2017: FLXN,CYTX,MDGS", "Stocks To Watch: Flexion Therapeutics Sees RS Rating Jump To 83", "Flexion Therapeutics Getting Closer To Key Technical Measure", "Flexion's (FLXN) Zilretta Therapy to Fast Capture OA Market", "Flexion Therapeutics (FLXN) in Focus: Stock Moves 10.4% Higher", "Pre-Market Most Active for Oct 9, 2017 : CHL, LYG, GSK, GE, ERIC, MNKD, SWCH, NVO, FLXN, AMKR, QQQ, TVIX", "Flexion Therapeutics Clears Technical Benchmark, Hitting 90-Plus RS Rating", "This Biotech Could Reap North Of $1 Billion For Painkiller", "Insiders Were Right: FLXN Makes New 52-Week High", "Flexion Therapeutics Hits 80-Plus Relative Strength Rating Benchmark", "Big Day on Deck for Flexion Therapeutics", "Flexion's Zilretta Gets FDA Approval for Knee Pain, Stock Up", "Stocks Showing Rising Market Leadership: Flexion Therapeutics Earns 85 RS Rating", "Flexion Therapeutics Sees Relative Strength Rating Improve To 75", "Implied Volatility Surging for Flexion Therapeutics (FLXN) Stock Options", "Why Flexion Therapeutics Shares Shot 12.8% Higher in July", "3 Biotech Stocks With Big News Coming", "3 Exciting Biotechs Under $30: Flexion Therapeutics' Response to the Opioid Epidemic", "3 Hot Healthcare Stocks Under $30", "The Zacks Analyst Blog Highlights: Flexion Therapeutics, Alexion Pharmaceuticals, PTC Therapeutics, Johnson & Johnson and TESARO", "4 Sell-Ranked Drug Stocks to Avoid Ahead of Q2 Earnings", "Why Flexion Therapeutics Rallied 18% in June", "Why VWR Corp. Is Soaring Today", "Why Flexion Therapeutics Inc. Stock Is Tanking", "Health Care Sector Update for 04/26/2017: MDSO,AKBA,FLXN", "Health Care Sector Update for 04/26/2017: MNOV,AKBA,FLXN", "Why Flexion Therapeutics' New Pain Drug Could Be a Game-Changer", "The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Flexion Therapeutics, Ignyta and Anika Therapeutics", "4 Sell-Ranked Drug Stocks to Avoid Ahead of Q2 Earnings", "Why Flexion Therapeutics Rallied 18% in June", "Here's Why Flexion Therapeutics Inc. Skyrocketed Today", "Flexion (FLXN) Stock Soars 35% on $1 Billion Sanofi Buyout", "Thursday's ETF Movers: IWC, GDXJ", "After-Hours Earnings Report for March 9, 2017 : ULTA, FNSR, PAY, TAHO, SGRY, MMI, ERI, IMOS, MYRG, PRSC, FLXN, ZUMZ", "Can Drugmakers Cure the Opioid Crisis?", "2 Red-Hot Biotechs to Buy Ahead of FDA Decisions", "Can Flexion Therapeutics Add Some Muscle to Your Portfolio?", "Why Shares of Flexion Therapeutics, Inc., Lantheus Holdings Inc, and PDL BioPharma Inc Are Tanking Today", "Noteworthy Friday Option Activity: AWI, OMF, FLXN", "3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions", "Sum Up The Parts: Russell 2000 Has 11% Upside", "How Flexion (FLXN) Stock Stands Out in a Strong Industry", "3 Drugs Heading to the FDA Soon", "2 Red-Hot Biotechs to Buy Ahead of FDA Decisions", "Can Flexion Therapeutics Add Some Muscle to Your Portfolio?", "Why Shares of Flexion Therapeutics, Inc., Lantheus Holdings Inc, and PDL BioPharma Inc Are Tanking Today", "Why Flexion Therapeutics Inc (FLXN), Micron Technology, Inc. (MU) and VeriFone Systems Inc (PAY) Are Three of Today\u2019s Worst Stocks", "Why Flexion Therapeutics Took a 12.8% Nosedive Today", "3 Biotech Stocks Billionaires Are Buying That I'm Buying, Too", "Flexion (FLXN) Zilretta Gets Positive FDA Guidance; Stock Up", "Flexion Therapeutics (FLXN) Stock: Moving Average Crossover Alert", "Midday Update: Rally Runs Out of Steam as Wall Street Braces For Yellen", "Close Update: Stocks Turn Defensive Ahead of Yellen's Speech", "Notable Thursday Option Activity: FLXN, TSRO, GOGO", "How The Parts Add Up: IBB Targets $388", "Health Care Sector Update for 04/04/2016: FLXN,OCX,IRMD", "Monday Sector Leaders: Drugs, Biotechnology Stocks", "Why Flexion Therapeutics Bolted Higher Today", "2 Sizzling-Hot Biotech Stocks to Buy", "Midday Update: Rally Runs Out of Steam as Wall Street Braces For Yellen", "SurModics (SRDX) Q4 Earnings, Revenues Beat Estimates", "Alnylam (ALNY) Reports Positive Interim Data on ALN-PCSsc", "Notable Thursday Option Activity: GPRO, LOCO, FLXN", "Shire Beats on Q3 Earnings & Revenues, Maintains View", "No pain, more gains: Axsome Therapeutics files for a $58 million IPO", "Health Care Sector Update for 02/17/2016: FLXN,OCUL,CPRX", "Flexion's (FLXN) Pain Drug Zilretta Tops Phase III Study", "Is Flexion Therapeutics (FLXN) Stock a Solid Choice Right Now?", "SurModics (SRDX) Q4 Earnings, Revenues Beat Estimates", "Can the Rally in Flexion Therapeutics (FLXN) Shares Continue? - Tale of the Tape", "Top Momentum Stocks for the Week - (FLXN) (KBR) - Video Blog", "Egalet Slumps: EGLT Falls 7.3% in Session - Tale of the Tape", "Why Flexion Therapeutics (FLXN) Could Be Positioned for a Surge? - Tale of the Tape", "Ampio (AMPE) Starts Final Phase III Study on Knee Pain Drug", "Why Flexion Therapeutics (FLXN) Stock Might be a Great Pick - Tale of the Tape", "Will Flexion (FLXN) Continue to Surge Higher? - Tale of the Tape", "Flexion Therapeutics (FLXN) Shares March Higher, Can It Continue? - Tale of the Tape", "Flexion Therapeutics (FLXN): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape", "Flexion Therapeutics (FLXN) Worth Watching: Stock Up 9.2% - Tale of the Tape", "Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog", "Can the Rally in Flexion Therapeutics (FLXN) Shares Continue? - Tale of the Tape", "Increased Earnings Estimates Seen for Flexion Therapeutics (FLXN): Can It Move Higher? - Tale of the Tape", "Why Flexion Therapeutics (FLXN) Stock Might be a Great Pick - Tale of the Tape", "Will Flexion (FLXN) Continue to Surge Higher? - Tale of the Tape", "Flexion Therapeutics (FLXN) Shares March Higher, Can It Continue? - Tale of the Tape", "Will Flexion (FLXN) Continue to Surge Higher? - Tale of the Tape", "Health IPOs down 1% and housing IPOs trade up after heavy discount", "Healthcare Stocks Narrowly Mixed This Afternoon; Flexion Climbs As Much as 24% After $65 Mln IPO", "Sector Update: Health Care Stocks Climbing in Afternoon Trade; Flexion Therapeutics Slips After FDA Suspends Testing of Company's Pain Medication", "Flexion Therapeutics prices IPO at $13 midpoint", "9 US IPOs planned for the week of Feb 10", "Pain biotech Flexion Therapeutics sets terms for $65 million IPO", "Sector Update: Healthcare"], "Elapsed Time": ["MAY 28, 2020", "MAY 28, 2020", "MAY 21, 2020", "MAY 21, 2020", "MAY 21, 2020", "MAY 9, 2020", "MAR 13, 2020", "FEB 29, 2020", "MAY 28, 2020", "JAN 28, 2020", "DEC 27, 2019", "DEC 27, 2019", "DEC 27, 2019", "DEC 27, 2019", "DEC 18, 2019", "DEC 12, 2019", "FEB 7, 2020", "OCT 24, 2019", "OCT 15, 2019", "OCT 14, 2019", "OCT 14, 2019", "OCT 14, 2019", "OCT 14, 2019", "OCT 9, 2019", "NOV 11, 2019", "OCT 24, 2019", "OCT 15, 2019", "OCT 14, 2019", "OCT 14, 2019", "OCT 14, 2019", "OCT 14, 2019", "FEB 28, 2019", "SEP 27, 2019", "FEB 11, 2019", "JAN 3, 2019", "DEC 11, 2018", "NOV 7, 2018", "SEP 24, 2018", "JUL 2, 2018", "JUN 27, 2018", "FEB 21, 2019", "APR 3, 2018", "MAR 8, 2018", "DEC 29, 2017", "DEC 29, 2017", "DEC 11, 2017", "DEC 10, 2017", "DEC 4, 2017", "APR 6, 2018", "NOV 29, 2017", "NOV 28, 2017", "NOV 27, 2017", "NOV 27, 2017", "NOV 24, 2017", "NOV 16, 2017", "NOV 6, 2017", "NOV 30, 2017", "OCT 9, 2017", "OCT 9, 2017", "OCT 9, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 5, 2017", "OCT 9, 2017", "OCT 3, 2017", "SEP 29, 2017", "SEP 19, 2017", "AUG 7, 2017", "AUG 2, 2017", "AUG 2, 2017", "JUL 31, 2017", "OCT 3, 2017", "JUL 17, 2017", "JUL 6, 2017", "MAY 3, 2017", "APR 26, 2017", "APR 26, 2017", "APR 26, 2017", "APR 19, 2017", "JUL 18, 2017", "JUL 17, 2017", "JUL 6, 2017", "MAR 23, 2017", "MAR 23, 2017", "MAR 23, 2017", "MAR 9, 2017", "APR 18, 2017", "NOV 29, 2016", "NOV 17, 2016", "NOV 16, 2016", "SEP 23, 2016", "SEP 21, 2016", "SEP 21, 2016", "AUG 26, 2016", "DEC 12, 2016", "NOV 29, 2016", "NOV 17, 2016", "NOV 16, 2016", "JUN 8, 2016", "JUN 8, 2016", "JUN 7, 2016", "MAY 27, 2016", "JUL 29, 2016", "MAY 26, 2016", "MAY 26, 2016", "MAY 26, 2016", "APR 21, 2016", "APR 4, 2016", "APR 4, 2016", "FEB 17, 2016", "MAY 27, 2016", "MAY 26, 2016", "NOV 12, 2015", "NOV 12, 2015", "NOV 12, 2015", "OCT 26, 2015", "OCT 13, 2015", "FEB 17, 2016", "FEB 17, 2016", "DEC 29, 2015", "NOV 12, 2015", "JUL 14, 2015", "JUL 6, 2015", "JUL 1, 2015", "JUN 15, 2015", "SEP 23, 2015", "JAN 13, 2015", "JAN 13, 2015", "DEC 18, 2014", "DEC 16, 2014", "DEC 15, 2014", "SEP 22, 2014", "JUN 9, 2015", "JAN 20, 2015", "JAN 13, 2015", "JAN 13, 2015", "SEP 5, 2014", "AUG 15, 2014", "FEB 13, 2014", "FEB 12, 2014", "SEP 18, 2014", "FEB 11, 2014", "FEB 10, 2014", "JAN 29, 2014", "FEB 12, 2014"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/abio-jumps-on-joining-covid-19-drug-fray-gmab-hits-trial-goal-imra-on-watch-2020-05-28", "https://www.nasdaq.com/articles/why-boeing-stock-is-up-2020-05-28", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-l-brands-akorn-aurora-cannabis-2020-05-21", "https://www.nasdaq.com/articles/why-flexion-therapeutics-is-tumbling-10-today-2020-05-21", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-akorn-l-brands-aurora-cannabis-2020-05-21", "https://www.nasdaq.com/articles/flexion-therapeutics-inc-flxn-q1-2020-earnings-call-transcript-2020-05-09", "https://www.nasdaq.com/articles/flexion-therapeutics-inc-flxn-q4-2019-earnings-call-transcript-2020-03-13", "https://www.nasdaq.com/articles/3-high-risk-high-reward-stocks-that-have-massive-upside-potential-2020-02-29", "https://www.nasdaq.com/articles/abio-jumps-on-joining-covid-19-drug-fray-gmab-hits-trial-goal-imra-on-watch-2020-05-28", "https://www.nasdaq.com/articles/5-strong-buy-biotech-stocks-to-buy-for-2020-2020-01-28", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-27-2019%3A-dcphmbotflxnmlnt-2019-12-27", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-27-2019%3A-mbotflxnmlnt-2019-12-27", "https://www.nasdaq.com/articles/why-flexion-therapeutics-stock-is-flying-higher-today-2019-12-27", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-27-2019%3A-flxn-fprx-sppi-jnj-pfe-abt-mrk-amgn-2019-12-27", "https://www.nasdaq.com/articles/flexion-awaits-fda-word-on-revised-zilretta-label-2019-12-18", "https://www.nasdaq.com/articles/should-investors-up-the-ante-on-these-3-strong-buy-stocks-2019-12-12", "https://www.nasdaq.com/articles/3-canadian-biotechs-to-consider-buying-today-2020-02-07", "https://www.nasdaq.com/articles/5-strong-buy-biotech-stocks-with-rapidly-approaching-catalysts-2019-10-24", "https://www.nasdaq.com/articles/reta-surges-on-trial-data-rvnc-on-track-all-eyes-on-rlmd-today-2019-10-15", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-14-2019%3A-ctstapyxflxnagnabbv-2019-10-14", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-14-2019%3A-apyxflxnagnabbv-2019-10-14", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-14-2019%3A-imrn-cerc-aytu-flxn-jnj-pfe-abt-mrk-amgn-2019-10", "https://www.nasdaq.com/articles/3-top-biotech-stocks-with-major-catalysts-in-october-2019-10-14", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-flxn-myok-gts-2019-10-09", "https://www.nasdaq.com/articles/flexion-therapeutics-inc-flxn-q3-2019-earnings-call-transcript-2019-11-11", "https://www.nasdaq.com/articles/5-strong-buy-biotech-stocks-with-rapidly-approaching-catalysts-2019-10-24", "https://www.nasdaq.com/articles/reta-surges-on-trial-data-rvnc-on-track-all-eyes-on-rlmd-today-2019-10-15", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-14-2019%3A-ctstapyxflxnagnabbv-2019-10-14", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-14-2019%3A-apyxflxnagnabbv-2019-10-14", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-14-2019%3A-imrn-cerc-aytu-flxn-jnj-pfe-abt-mrk-amgn-2019-10", "https://www.nasdaq.com/articles/6-top-losers-healthcare-sector-otlk-wve-phas...-2019-04-10", "https://www.nasdaq.com/articles/flexion-therapeutics-inc-flxn-q4-2018-earnings-conference-call-transcript-2019-02-28", "https://www.nasdaq.com/articles/biotech-stocks-facing-fda-decision-in-october-2019-2019-09-27", "https://www.nasdaq.com/articles/heres-why-flexion-therapeutics-rose-298-january-2019-02-11", "https://www.nasdaq.com/articles/flexion-starts-phase-iii-enrollment-on-zilretta-for-hip-oa-2019-01-03", "https://www.nasdaq.com/articles/heres-why-flexion-therapeutics-jumped-205-november-2018-12-11", "https://www.nasdaq.com/articles/flexion-therapeutics-flxn-reports-q3-loss-tops-revenue-estimates-2018-11-07", "https://www.nasdaq.com/articles/commit-buy-flexion-therapeutics-1250-earn-81-annualized-using-options-2018-09-24", "https://www.nasdaq.com/articles/flexion-therapeutics-shares-cross-below-200-dma-2018-07-02", "https://www.nasdaq.com/articles/5-biotech-stocks-that-could-be-the-next-amgen-2018-06-27", "https://www.nasdaq.com/articles/flexion-therapeutics-flxn-may-report-negative-earnings%3A-know-the-trend-ahead-of-next-weeks", "https://www.nasdaq.com/articles/why-flexion-therapeutics-jumped-126-today-2018-04-03", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-8-2018-coo-mrvl-zto-fnsr-unfi-pay-myok-terp-mmi-bold", "https://www.nasdaq.com/articles/3-biotechs-launching-their-first-commercial-drugs-2018-2017-12-29", "https://www.nasdaq.com/articles/flexion-therapeutics-getting-closer-key-technical-measure-2017-12-29", "https://www.nasdaq.com/articles/notable-monday-option-activity-khc-rgld-flxn-2017-12-11", "https://www.nasdaq.com/articles/2018-critical-year-these-3-small-commercial-stage-biotech-stocks-2017-12-10", "https://www.nasdaq.com/articles/top-insiders-are-buying-these-3-strong-buy-healthcare-stocks-2017-12-04", "https://www.nasdaq.com/articles/why-flexion-therapeutics-flxn-could-be-positioned-for-a-slump-2018-04-06", "https://www.nasdaq.com/articles/stocks-watch-flexion-therapeutics-sees-rs-rating-jump-83-2017-11-29", "https://www.nasdaq.com/articles/small-cap-biotech-stock-something-big-2017-11-28", "https://www.nasdaq.com/articles/notable-monday-option-activity-flxn-ver-avgo-2017-11-27", "https://www.nasdaq.com/articles/stocks-watch-flexion-therapeutics-sees-relative-strength-rating-jump-88-2017-11-27", "https://www.nasdaq.com/articles/health-care-sector-update-11242017-flxncytxmdgs-2017-11-24", "https://www.nasdaq.com/articles/stocks-watch-flexion-therapeutics-sees-rs-rating-jump-83-2017-11-16", "https://www.nasdaq.com/articles/flexion-therapeutics-getting-closer-key-technical-measure-2017-11-06", "https://www.nasdaq.com/articles/flexions-flxn-zilretta-therapy-to-fast-capture-oa-market-2017-11-30", "https://www.nasdaq.com/articles/flexion-therapeutics-flxn-in-focus%3A-stock-moves-10.4-higher-2017-10-09", "https://www.nasdaq.com/articles/pre-market-most-active-oct-9-2017-chl-lyg-gsk-ge-eric-mnkd-swch-nvo-flxn-amkr-qqq-tvix", "https://www.nasdaq.com/articles/flexion-therapeutics-clears-technical-benchmark-hitting-90-plus-rs-rating-2017-10-09", "https://www.nasdaq.com/articles/biotech-could-reap-north-1-billion-painkiller-2017-10-06", "https://www.nasdaq.com/articles/insiders-were-right-flxn-makes-new-52-week-high-2017-10-06", "https://www.nasdaq.com/articles/flexion-therapeutics-hits-80-plus-relative-strength-rating-benchmark-2017-10-06", "https://www.nasdaq.com/articles/big-day-deck-flexion-therapeutics-2017-10-05", "https://www.nasdaq.com/articles/flexions-zilretta-gets-fda-approval-for-knee-pain-stock-up-2017-10-09", "https://www.nasdaq.com/articles/stocks-showing-rising-market-leadership-flexion-therapeutics-earns-85-rs-rating-2017-10-03", "https://www.nasdaq.com/articles/flexion-therapeutics-sees-relative-strength-rating-improve-75-2017-09-29", "https://www.nasdaq.com/articles/implied-volatility-surging-for-flexion-therapeutics-flxn-stock-options-2017-09-19", "https://www.nasdaq.com/articles/why-flexion-therapeutics-shares-shot-128-higher-july-2017-08-07", "https://www.nasdaq.com/articles/3-biotech-stocks-big-news-coming-2017-08-02", "https://www.nasdaq.com/articles/3-exciting-biotechs-under-30-flexion-therapeutics-response-opioid-epidemic-2017-08-02", "https://www.nasdaq.com/articles/3-hot-healthcare-stocks-under-30-2017-07-31", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-flexion-therapeutics-alexion-pharmaceuticals-ptc", "https://www.nasdaq.com/articles/4-sell-ranked-drug-stocks-avoid-ahead-q2-earnings-2017-07-17", "https://www.nasdaq.com/articles/why-flexion-therapeutics-rallied-18-june-2017-07-06", "https://www.nasdaq.com/articles/why-vwr-corp-soaring-today-2017-05-03", "https://www.nasdaq.com/articles/why-flexion-therapeutics-inc-stock-tanking-2017-04-26", "https://www.nasdaq.com/articles/health-care-sector-update-04262017-mdsoakbaflxn-2017-04-26", "https://www.nasdaq.com/articles/health-care-sector-update-04262017-mnovakbaflxn-2017-04-26", "https://www.nasdaq.com/articles/why-flexion-therapeutics-new-pain-drug-could-be-game-changer-2017-04-19", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-valeant-pharmaceuticals-international-flexion", "https://www.nasdaq.com/articles/4-sell-ranked-drug-stocks-avoid-ahead-q2-earnings-2017-07-17", "https://www.nasdaq.com/articles/why-flexion-therapeutics-rallied-18-june-2017-07-06", "https://www.nasdaq.com/articles/heres-why-flexion-therapeutics-inc-skyrocketed-today-2017-03-23", "https://www.nasdaq.com/articles/flexion-flxn-stock-soars-35-1-billion-sanofi-buyout-2017-03-23", "https://www.nasdaq.com/articles/thursdays-etf-movers-iwc-gdxj-2017-03-23", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-9-2017-ulta-fnsr-pay-taho-sgry-mmi-eri-imos-myrg-prsc", "https://www.nasdaq.com/articles/can-drugmakers-cure-opioid-crisis-2017-04-18", "https://www.nasdaq.com/articles/2-red-hot-biotechs-buy-ahead-fda-decisions-2016-11-29", "https://www.nasdaq.com/articles/can-flexion-therapeutics-add-some-muscle-your-portfolio-2016-11-17", "https://www.nasdaq.com/articles/why-shares-flexion-therapeutics-inc-lantheus-holdings-inc-and-pdl-biopharma-inc-are", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-awi-omf-flxn-2016-09-23", "https://www.nasdaq.com/articles/3-clinical-stage-biotechs-buy-ahead-fda-decisions-2016-09-21", "https://www.nasdaq.com/articles/sum-parts-russell-2000-has-11-upside-2016-09-21", "https://www.nasdaq.com/articles/how-flexion-flxn-stock-stands-out-in-a-strong-industry-2016-08-26", "https://www.nasdaq.com/articles/3-drugs-heading-fda-soon-2016-12-12", "https://www.nasdaq.com/articles/2-red-hot-biotechs-buy-ahead-fda-decisions-2016-11-29", "https://www.nasdaq.com/articles/can-flexion-therapeutics-add-some-muscle-your-portfolio-2016-11-17", "https://www.nasdaq.com/articles/why-verifone-systems-flexion-therapeutics-and-mts-systems-are-slumping-today-2016-06-08", "https://www.nasdaq.com/articles/why-flexion-therapeutics-inc-flxn-micron-technology-inc.-mu-and-verifone-systems-inc-pay", "https://www.nasdaq.com/articles/why-flexion-therapeutics-took-128-nosedive-today-2016-06-08", "https://www.nasdaq.com/articles/3-biotech-stocks-billionaires-are-buying-im-buying-too-2016-06-07", "https://www.nasdaq.com/articles/flexion-flxn-zilretta-gets-positive-fda-guidance-stock-up-2016-05-27", "https://www.nasdaq.com/articles/flexion-therapeutics-flxn-stock%3A-moving-average-crossover-alert-2016-07-29", "https://www.nasdaq.com/articles/midday-update-rally-runs-out-steam-wall-street-braces-yellen-2016-05-26", "https://www.nasdaq.com/articles/close-update-stocks-turn-defensive-ahead-yellens-speech-2016-05-26", "https://www.nasdaq.com/articles/notable-thursday-option-activity-flxn-tsro-gogo-2016-05-26", "https://www.nasdaq.com/articles/how-parts-add-ibb-targets-388-2016-04-21", "https://www.nasdaq.com/articles/health-care-sector-update-04042016-flxnocxirmd-2016-04-04", "https://www.nasdaq.com/articles/monday-sector-leaders-drugs-biotechnology-stocks-2016-04-04", "https://www.nasdaq.com/articles/why-flexion-therapeutics-bolted-higher-today-2016-02-17", "https://www.nasdaq.com/articles/2-sizzling-hot-biotech-stocks-buy-2016-05-27", "https://www.nasdaq.com/articles/midday-update-rally-runs-out-steam-wall-street-braces-yellen-2016-05-26", "https://www.nasdaq.com/articles/surmodics-srdx-q4-earnings-revenues-beat-estimates-2015-11-12", "https://www.nasdaq.com/articles/alnylam-alny-reports-positive-interim-data-on-aln-pcssc-2015-11-12", "https://www.nasdaq.com/articles/notable-thursday-option-activity-gpro-loco-flxn-2015-11-12", "https://www.nasdaq.com/articles/shire-beats-on-q3-earnings-revenues-maintains-view-2015-10-26", "https://www.nasdaq.com/articles/no-pain-more-gains-axsome-therapeutics-files-58-million-ipo-2015-10-13", "https://www.nasdaq.com/articles/health-care-sector-update-02172016-flxnoculcprx-2016-02-17", "https://www.nasdaq.com/articles/flexions-flxn-pain-drug-zilretta-tops-phase-iii-study-2016-02-17", "https://www.nasdaq.com/articles/is-flexion-therapeutics-flxn-stock-a-solid-choice-right-now-2015-12-29", "https://www.nasdaq.com/articles/health-care-sector-update-09092015-flxn-vtae-ttph-2015-09-09", "https://www.nasdaq.com/articles/can-the-rally-in-flexion-therapeutics-flxn-shares-continue-tale-of-the-tape-2015-07-14", "https://www.nasdaq.com/articles/top-momentum-stocks-week-flxn-kbr-video-blog-2015-07-06", "https://www.nasdaq.com/articles/egalet-slumps%3A-eglt-falls-7.3-in-session-tale-of-the-tape-2015-07-01", "https://www.nasdaq.com/articles/why-flexion-therapeutics-flxn-could-be-positioned-for-a-surge-tale-of-the-tape-2015-06-15", "https://www.nasdaq.com/articles/ampio-ampe-starts-final-phase-iii-study-on-knee-pain-drug-2015-09-23", "https://www.nasdaq.com/articles/why-flexion-therapeutics-flxn-stock-might-be-a-great-pick-tale-of-the-tape-2015-01-13", "https://www.nasdaq.com/articles/will-flexion-flxn-continue-to-surge-higher-tale-of-the-tape-2015-01-13", "https://www.nasdaq.com/articles/flexion-therapeutics-flxn-shares-march-higher-can-it-continue-tale-of-the-tape-2014-12-18", "https://www.nasdaq.com/articles/flexion-therapeutics-flxn%3A-strong-industry-solid-earnings-estimate-revisions-tale-of-the", "https://www.nasdaq.com/articles/flexion-therapeutics-flxn-worth-watching%3A-stock-up-9.2-tale-of-the-tape-2014-12-15", "https://www.nasdaq.com/articles/flexion-continues-to-fall-post-clinical-hold-on-fx006-analyst-blog-2014-09-22", "https://www.nasdaq.com/articles/can-the-rally-in-flexion-therapeutics-flxn-shares-continue-tale-of-the-tape-2015-06-09", "https://www.nasdaq.com/articles/increased-earnings-estimates-seen-for-flexion-therapeutics-flxn%3A-can-it-move-higher-tale", "https://www.nasdaq.com/articles/why-flexion-therapeutics-flxn-stock-might-be-a-great-pick-tale-of-the-tape-2015-01-13", "https://www.nasdaq.com/articles/will-flexion-flxn-continue-to-surge-higher-tale-of-the-tape-2015-01-13", "https://www.nasdaq.com/articles/flexion-therapeutics-flxn-jumps%3A-stock-rises-9.4-tale-of-the-tape-2014-09-05", "https://www.nasdaq.com/articles/will-flexion-flxn-continue-to-surge-higher-tale-of-the-tape-2014-08-15", "https://www.nasdaq.com/articles/health-ipos-down-1-and-housing-ipos-trade-after-heavy-discount-2014-02-13", "https://www.nasdaq.com/articles/healthcare-stocks-narrowly-mixed-afternoon-flexion-climbs-much-24-after-65-mln-ipo-2014-02", "https://www.nasdaq.com/articles/sector-update-health-care-stocks-climbing-afternoon-trade-flexion-therapeutics-slips-after", "https://www.nasdaq.com/articles/flexion-therapeutics-prices-ipo-13-midpoint-2014-02-11", "https://www.nasdaq.com/articles/9-us-ipos-planned-week-feb-10-2014-02-10", "https://www.nasdaq.com/articles/pain-biotech-flexion-therapeutics-sets-terms-65-million-ipo-2014-01-29", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-02-12-0"], "Content": []}